Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2014
11/27/2014US20140349994 Novel 2-Amino-4,5,6,8-Tetrahydropyrazolo[3,4-b]Thiazolo [4,5-d]Azepine Derivatives and Their Use as Allosteric Modulators of Metabotropic Glutamate Receptors
11/27/2014US20140349990 Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease
11/27/2014US20140349989 Compounds and therapeutic uses thereof
11/27/2014US20140349988 Organonitro thioether compounds and medical uses thereof
11/27/2014US20140349976 Co-administration of pimavanserin with other agents
11/27/2014US20140349965 Compositions and methods for treating neoplastic diseases
11/27/2014US20140349955 Use of fluorine-containing water soluble platinum complex in preparing drugs for prevention and treatment of cancers
11/27/2014US20140349943 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
11/27/2014US20140349931 Detection and treatment of breast cancer
11/27/2014US20140349930 Treatment using neublastin polypeptides
11/27/2014US20140349927 Ladostigil Therapy For Immunomodulation
11/27/2014US20140349921 Hcv ns3 protease inhibitors
11/27/2014US20140348959 Formulations and Methods for Treating Ear Conditions
11/27/2014US20140348958 Anticancer Active Ingredient From Guiera Senegalensis
11/27/2014US20140348955 Methods for improving the safety of treating pediatric patients who are candidates for inhaled nitric oxide treatment
11/27/2014US20140348942 Treatments for Gastrointestinal Disorders
11/27/2014US20140348923 Polymeric Drug-Delivery Material, Method For Manufacturing Thereof And Method For Delivery Of A Drug-Delivery Composition
11/27/2014US20140348902 Tcl1 peptides for immunotherapy
11/27/2014US20140348899 Method and composition for treating cystitis
11/27/2014US20140348853 Methods of treating rickettsia using exchange proteins directly activated by camp (epacs) inhibitors
11/27/2014US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein
11/27/2014US20140348847 Antibodies against human il-12
11/27/2014US20140348844 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
11/27/2014US20140348830 Interleukin-6 receptor binding polypeptides
11/27/2014US20140348829 Felinized Antibodies and Methods of Treating Retroviral Infections in Felines
11/27/2014US20140348827 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
11/27/2014US20140348821 Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer
11/27/2014US20140348819 Methods of Treating Cancer
11/27/2014US20140348814 Arginne deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
11/27/2014US20140348801 Treatment of Vocal Cords With Autologous Dermal Fibroblast Formulation
11/27/2014US20140348787 Methods and Compositions for Treating Ear Infections
11/27/2014US20140348786 Beta-mannosylceramide and stimulation of nkt cell anti-tumor immunity
11/27/2014US20140348785 Neutralizing gp41 antibodies and their use
11/27/2014US20140348783 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348782 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348780 Method of Enhanced Antibiotic Activity Via Chemotaxis
11/27/2014US20140348752 Methods for treating lysosomal acid lipase deficiency in patients
11/25/2014US8895755 Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
11/25/2014US8895737 Process for preparing antiviral compounds
11/25/2014US8895733 Triazine-oxadiazoles
11/25/2014US8895721 RNA interference mediating small RNA molecules
11/25/2014US8895718 RNA interference mediating small RNA molecules
11/25/2014US8895628 Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
11/25/2014US8895619 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
11/25/2014US8895598 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
11/25/2014US8895596 Cyclic benzimidazole derivatives useful as anti-diabetic agents
11/25/2014US8895586 Methods of treating emesis
11/25/2014US8895583 Soluble guanylate cyclase activators
11/25/2014US8895581 1H-imidazo[4,5-c]quinolines
11/25/2014US8895576 Methods of use of cyclopamine analogs
11/25/2014US8895575 1 H-pyrrolo[2,3-b]pyridine derivatives
11/25/2014US8895555 Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS
11/25/2014US8895549 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/25/2014US8895547 Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
11/25/2014US8895546 Administration of benzodiazepine compositions
11/25/2014US8895540 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
11/25/2014US8895539 Pregnancy hormone combination for treatment of autoimmune diseases
11/25/2014US8895538 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
11/25/2014US8895535 Pyrrolidinones as MetAP-2 inhibitors
11/25/2014US8895533 Starch derivative mixtures
11/25/2014US8895532 Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes
11/25/2014US8895529 Antisense modulation of fibroblast growth factor receptor 4 expression
11/25/2014US8895521 Methods and compositions for the treatment of uveitis
11/25/2014US8895509 MIR-200 family induces mesenchymal-to-epithelial transition (MET) in ovarian cancer cells
11/25/2014US8895502 β2-glycoprotein I peptide inhibitors
11/25/2014US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
11/25/2014US8895282 Use of a substance for manufacturing of a medicament for treatment of common cold
11/25/2014US8895081 Formulation for treatment of dry mouth and mouth sores
11/25/2014US8895079 Combinations of botanical extracts for promoting cardiovascular health
11/25/2014US8895075 Herbomineral formulation for treating sickle cell disease
11/25/2014US8895074 Therapeutic application of parenteral krill oil
11/25/2014US8895070 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
11/25/2014US8895065 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
11/25/2014US8895063 Oral dosage form comprising an antimisuse system
11/25/2014US8895061 Compositions comprising carisoprodol and methods of use thereof
11/25/2014US8895033 Sustained release formulations using non-aqueous carriers
11/25/2014US8895018 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
11/25/2014US8895010 Antibody polypeptides that antagonize CD40L
11/25/2014US8895001 Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
11/25/2014US8894996 Immunoadjuvant composition and use thereof
11/25/2014US8894994 Modified beta-lactamases and methods and uses related thereto
11/25/2014US8894991 Canine probiotic Lactobacilli
11/25/2014US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
11/25/2014US8894989 PARP inhibitor compounds, compositions and methods of use
11/25/2014US8894988 Tamper resistant dosage forms
11/25/2014US8894987 Tamper resistant dosage forms
11/25/2014US8894979 Composition containing at least one C7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails
11/25/2014US8894977 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound
11/20/2014US20140343347 Methods and related compositions for the treatment of cancer
11/20/2014US20140343167 Use of citral for treating focal segmental glomerulosclerosis
11/20/2014US20140343124 Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas
11/20/2014US20140343119 4-hydroxybutyric acid analogs
11/20/2014US20140343118 Methods of treatment using arylcyclopropylamine compounds
11/20/2014US20140343092 Pyrrolopyridinone Compounds And Methods For Treating HIV
11/20/2014US20140343091 Beta2-adrenoceptor agonists
11/20/2014US20140343077 Hepatitis c inhibitor compounds
11/20/2014US20140343076 Pharmaceutical compositions of lurasidone
11/20/2014US20140343071 Compositions and methods for treating cancer
11/20/2014US20140343069 Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
11/20/2014US20140343057 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 1151